… Venom immunotherapy (VIT) is highly effective in preventing … reactions to Hymenoptera
stings [1–3]. The choice of … More recently, better results were observed in a multicenter survey in …

… Clinical effectiveness of venom immunotherapy for Hymenoptera venom allergy: a
prospective observational multicenter study of the European Academy of Allergology and …

… venom immunotherapy is currently the most effective form of … The clinical efficacy of VIT can
be seen in the fact that it reduces … A recent multicenter study prospectively collected data on …

… Clinical effectiveness of venom immunotherapy for Hymenoptera venom allergy: A
prospective observational multicenter study of the European academy of allergology and …

… before initiating venom immunotherapy, evidence-based clinical … , and honeybee
venom-allergic patients with high risk of future … An EAACI multicenter study found a slightly …

… systemic sting reactions from the risk of future serious SAR … : results from an EAACI multicenter
study. Allergy. 2000;55(11… clinical effectiveness of Hymenoptera venom immunotherapy…

… venom immunotherapy (VIT), with an efficacy of up to 98% in humans. Prospective clinical
data on VIT efficacy … VIT efficacy was determined by observing patients’ clinical reactions to re-…

… sensitized people will have a future systemic sting reaction (… between 8 and 20% from large
multicenter studies (12, 13). In … be a more accurate measure of clinical efficacy and seems to …

… the terms ‘venom immunotherapy’ and ‘Hymenoptera venom … Concerning systemic
reactions, the two large multicenter … possibility of reacting to a future sting cannot be completely …

… reactors should be treated with venom immunotherapy (VIT). … The decision to start venom
immunotherapy (VIT) is based … European Academy of Allergy and Clinical Immunology (EAACI) …